PROGRAM

 

23th October

09:00-09:15 Opening

Chair: David Zaridze (Russia)

09:15-09:45 Plenary lecture: Treatment of gastric cancer-present state and perspectives. Ivan Stilidi (Russia)

09:45-10:15 Plenary lecture: New Concepts of Immune Checkpoint Inhibitor Treatment: Is Neoadjuvant Therapy an Option and Why? Christoph Zielinski (Austria)

COURSE A. ESOPHAGEAL & GASTRIC CANCER | ROOM 1 COURSE B. ОNCOGYNECOLOGY | ROOM 2 COURSE C. LUNG CANCER | ROOM 3

10:30-13:40 

Session A1. Surgical treatment of Esophageal and Gastric cancer
Chair: Pavel Kononets (Russia)

  • Staging and classification of gastric and esophago-gastric junction cancer. Michail Ter-Ovanesov (Russia)
  • Surgical treatment of patients with cancer of the esophagus and cardia. Pavel Kononets (Russia)
  • Surgical treatment of patients with gastric cancer. Alexey Kalinin (Russia)
  • Laparoscopic surgery for early gastric cancer. Maxim Nikulin (Russia)
  • Laparoscopic surgery of locally advanced gastric cancer. Igor Khatkov, Roman Izrailov (Russia)
  • Surgical removal of primary tumor in patients with primary metastatic gastric cancer: yes/ no. Natalia Besova (Russia)
    Q&A

14:00-16:10 

Session A2. Epidemiology and Prevention
Chair: David Zaridze (Russia)

  • Esophageal cancer: epidemiology and prevention. Eva Negri (Italy)
  • Gastric cancer: epidemiology and prevention. Carlo La Vecchia (Italy)
  • Hereditary esophageal and gastric cancer. Ludmila Lubchenko (Russia)
  • Early endoscopic diagnosis and treatment of gastric cancer.  Olga Malikhova (Russia)
    Q&A

10:30-14:30

Session B1. Epidemiology and Prevention
Chair: David Zaridze (Russia)

  • Introduction. David Zaridza (Russia)
  • Incidence and mortality of HPV-related cancersDavid Zaridze (Russia) 
  • The impact of vaccination in reducing the burden of HPV-related diseases is compelling. Elisabete Weiderpass (France)
  • HPV screening for cervical cancer. 

    Jack Сuzick (United Kingdom)

  • HPV FASTER. Broadening the scope of prevention. Joakim Dillner (Sweden)

  • Projection of cervical cancer incidence in the cohorts of vaccinated and not vaccinated Russian women. Iacopo Baussano (IARC, France)    
  • Validated HPV test systems for cervical cancer screening. Mario Poljak (Slovenia)
  • HPV screening. Russian experience. Ilya Olkov (Russia)
    Q&A

14:30-17:00 

Session B2. Cervical cancer
Chair: Аlexey Shevchuk (Russia)

  • The causes of failure in cytological screening for cervical cancer. Preinvasive disease. Lubov Korolenkova (Russia)
  • Mechanism of HPV Carcinogenesis. Svetlana Vinokurova (Russia)
  • Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. Heinz Kölbl (Austria)
  • The Organ saving treatment of cervical cancer. Аlexey Shevchuk (Russia)
  • Systemic treatment of cervical cancer (early and advanced). Anna Kedrova (Russia)
  • Immunotherapy of cervical cancer. Anna Kedrova (Russia)
  • Cervical cancer and pregnancy. Lubov Korolenkova (Russia)
    Q&A

10:30-12:40

Session C1. Immunotherapy of lung cancer
Chair: Sergey Orlov (Russia)

  • Immune Checkpoint Inhibitors in treatment of SCLC. Sergey Orlov (Russia)
  • Immune Checkpoint Inhibitors in treatment of NSCLC. Elena Artamonova (Russia)
  • Perspectives in first line treatment of NSCLC with high expression of PD-L1. Michail Ter-Ovanesov (Russia)
  • Management of brain metastases in advanced driver mutation-positive NSCLC. David Naskhletashvili (Russia)
  • Q&A

13:00-14:40

Session С2. Epidemiology and prevention
Chair: David Zaridze (Russia)

  • Epidemiology and prevention of lung cancer. David Zaridze (Russia)
  • Smoking cessation after diagnosis improves prognosis of lung cancer patients. Anush Mukeria (Russia)
  • Screening for lung cancer Andre Carvalho (France) 

    Q&A

15:00-16:40

Session С3. Surgical treatment
Chair: Pavel Kononets (Russia)

  • Interventional Bronchoscopy for management of early lung cancer. Olga Malikhova (Russia)
  • Open surgery in treatment of NSCLC. Walter Klepetko (Austria)
  • Video - Assisted Thoracoscopic Surgery (VATS). Pavel Kononets (Russia)
    Q&A

 

 

 

 

24th October

COURSE A. ESOPHAGEAL & GASTRIC CANCER | ROOM 1 COURSE B. ОNCOGYNECOLOGY | ROOM 2 COURSE C. LUNG CANCER | ROOM 3

10:00-12:10

Session A3. Medical Treatment of Esophageal & Gastric cancer 
Chairs: Christoph Zielinski (Austria), David Zaridze (Russia)

  • Her-2/neu Targeting in Gastric Cancer: Upcoming Drugs. Christoph Zielinski (Austria)
  • Immune Checkpoint Inhibitors in Gastric Cancer. Christoph Zielinski (Austria)
  • Personalized medical treatment of patients with primary disseminated gastric cancer. Natalia Besova (Russia)
  • Radiotherapy (brachytherapy) for cancer of the esophagus. Irina Gladilina (Russia) 
    Q&A

10:00-12:30

Session B3. Сancer of the ovary
Chair: Andrey Mechsheryakov (Russia)

  • Genetic susceptibility to ovarian cancer. Eugeniy Imyanitov (Russia)
  • Classification. Subtypes. Primary site assignment. Kirill Zhordaniа (Russia)
  • Surgery: Primary and interval debulking surgery. Valentina Nechushkina (Russia)
  • Standard therapy. Targeted therapy plus minus VEGF inhibitors. Immunotherapy? Valentina Nechushkina (Russia)
  • Management of BRCA mutation associated ovarian cancer. Andrey Mechsheryakov (Russia)
  • anagement of recurrent disease. Debulking surgery: pro/contra? Systemic treatment.  Alexey Schevchuk (Russia)
  • Management of brain metastasis of ovarian cancer. David Naskhletashvili (Russia)
     Q&A

12:30-13:00

Session B4. Endometrial cancer

  • Session B4. Cancer of the vulva and vagina
  • Cancer of the vulva and vagina - Diagnostic assessment, staging, surgical treatment and adjuvant radiotherapy. Elena Ulrikh (Russia)
    Q&A

13:10-14:20

Session B5. Endometrial cancer
Chair: Andrey Mechsheryakov (Russia)

  • Surgical treatment: Minimally invasive surgery, total hysterectomy with bilateral salpingo-oophorectomy with or without removal of pelvic and para-aortic lymph nodes. Heinz Kölbl (Austria)
  • Current status of brachytherapy in oncogynecology - modern principles, concepts, clinical results. Olga Kravets (Russia)
  • Malignant trophoblastic disease. Ludmila Meshcheryakova (Russia)
    Q&A

10:00-12:15

Session С4. Targeted therapy
Chair: David Zaridze (Russia)

  • Molecular characteristics of NSCLC. Lynnette Fernandez Cuesta (France)
  • Molecular characteristics of SCLC and neuro-endocrine lung tumours: the impact on their clinical management. Lynnette Fernandez Cuesta (France)
  • Treatment of EGFR positive NSCLC. Tanja Cufer (Slovenia) 
  • Treatment of ALK positive NSCLC. Tanja Cufer (Slovenia)
  • Q&A

12:30-13:40

Session С5Imaging diagnostics
Chair: Igor Tyurin (Russia) 

  • Imaging modalitiesIgor Tyurin (Russia) 
  • Image-guided intervention diagnosis. Dimitry Marinov (Russia)
    Q&A

13:40-14:50

Session С6Radiotherapy

  • Radiofrequency Ablation (RFA). Vladislav Kosirev (Russia)
  • Stereotactic body radiotherapy. Alexey Nazarenko (Russia)
    Q&A

 

 

back to top